Dr. Franz Köhler Chemie GmbH Expands Presence in Asia with New Joint Venture

Bensheim, May 2023 – Dr. Franz Köhler Chemie GmbH has taken a pivotal step in expanding its global reach by launching Koehler Pharmaceuticals Asia Pte Ltd, a new joint venture headquartered in Singapore. This strategic initiative underscores the company’s commitment to strengthening its presence in the Asian market and supporting long-term growth across the region.

Through the challenges posed by the Covid-19 pandemic, Dr. Franz Köhler Chemie GmbH's partnerships with Asian distributors have demonstrated exceptional resilience, underscoring the strength and reliability of these regional collaborations.

With a keen focus on advancing healthcare solutions in heart surgery and organ transplantation, Dr. Franz Köhler Chemie GmbH is actively investing to establish a solid presence across Asia's diverse time zones and healthcare landscapes.

To support this endeavor, Dr. Franz Köhler Chemie GmbH has joined forces with the Melchers Group as a minority joint venture partner. With deep roots in Asia dating back to the 1850s, Melchers Group brings valuable expertise in commercial strategy and regulatory compliance. Joining the board is Mr. Alexander Melchers, a leader with over 25 years of experience in Singapore, who will strengthen the joint commitment to building sustainable, cooperative alliances.

The creation of Koehler Pharmaceuticals Asia Pte Ltd, in partnership with Melchers Group, marks a significant milestone for Dr. Franz Köhler Chemie GmbH, furthering its mission to deliver impactful healthcare solutions across Asia and drive sustainable growth in this dynamic region.